Madam Speaker, I am very pleased to rise today to speak in support of Bill C-37, an act that would better equip both health and law enforcement officials to reduce the supply of illicit opioids and other drugs and to reduce the risk of diversion of controlled substances.
Bill C-37 confirms once again our government's continued commitment to ensuring that our legislative frameworks for public health and safety are modern and effective.
Bill C-37 is further evidence of our government's continued commitment to ensuring that our legislative frameworks related to public health and public safety are both modern and effective.
Protecting public health through efforts to prevent disease, prolong life, and promote health is a key priority for the government. The recently announced Canadian drugs and substances strategy and the proposed legislative changes to streamline the application process for supervised consumption sites are just two ways the Government of Canada is demonstrating this commitment to public health.
This new strategy is comprehensive, collaborative and compassionate. It is comprised of four key pillars: prevention, treatment, harm reduction and enforcement, which are built upon a strong foundation of evidence.
While the new strategy places an increased emphasis on public health, our government recognizes that effective drug policy must balance both public health and public safety.
Therefore, not only does Bill C-37 address harm reduction measures such as supervised injection sites, it also proposes new ways to deal with controlled substances that are obtained through illicit sources.
Therefore, not only does Bill C-37 address harm reduction measures such as supervised consumption sites, it also proposes new ways to deal with controlled substances that are obtained through illicit sources.
Bill C-37 would amend the Controlled Drugs and Substances Act, or the CDSA, Canada's drug control statute. The CDSA provides a framework to control substances that can alter mental processes and that may produce harm to health and to society when diverted or misused. It has the dual purpose of protecting public health and maintaining public safety.
We know that the use of illicit substances can increase the risk of harm to health. The CDSA maintains public safety by restricting the activities such as import, export and trafficking of controlled substances and precursors.
The Controlled Drugs and Substances Act has been in effect for two decades now and some of its regulations, enacted under previous legislation, have been in place much longer. While the CDSA serves us well in many areas, there has been a significant evolution in both the legitimate controlled substances and precursors industries as well as the illicit drug market.
The CDSA has been in force for two decades now, and some of its regulations have been in place for much longer, having first been enacted under old statutes. While the CDSA serves us well in many areas, there has been a significant evolution in both the legitimate controlled substance and precursor industries as well as the illicit drug market.
As we all know, problematic substance use is a serious public health issue. Our government is very concerned about the increasing rates of opioid-related overdose deaths occurring across Canada right now, and the devastating impact this crisis is having on individuals, families and communities at large, including in my own riding of Edmonton Centre. Opioid-related overdoses in British Columbia and Alberta have reached a crisis point and urgent action is needed to protect public health and safety, and disrupt illegal production and trafficking. It is becoming increasingly critical to ensure that the CDSA is modernized in order to better protect Canadians, their families, and the communities in which they live.
The Government of Canada is taking concrete action that will help address the current crisis and keep deadly drugs such as fentanyl and carfentanil out of Canadian communities. If the proposed amendments in Bill C-37 were adopted, they would further strengthen and modernize the tools available to the government to combat the illegal production and distribution of drugs and reduce the risk of controlled substances being diverted to the illegal market.
The Government of Canada is taking concrete actions that will help to address the ongoing crisis and keep deadly drugs like illicit fentanyl and carfentanil out of Canadian communities. If passed, these amendments will further strengthen and modernize the tools available to the government to combat the illegal production and distribution of drugs and reduce the risk of controlled substances being diverted to the illegal market.
One such action would prohibit the import of unregistered pill press and encapsulator devices.
Pill presses and encapsulators can be used legitimately to manufacture pharmaceuticals, food and consumer products as well. However, they may also be used to make illegal counterfeit drugs that look like legitimate pharmaceuticals. These counterfeit pills can contain dangerous substances such as fentanyl and W-18. Pill presses can produce thousands of illegal pills in a short period of time, which poses significant risks to the public health and safety of Canadians. Currently these devices can be legally imported into Canada without specific regulatory requirements.
Bill C-37 would require that every pill press and encapsulator imported into Canada be registered with Health Canada. This would serve as a tool to better equip law enforcement to reduce the supply of illicit opioids and other drugs in Canada. Proof of registration would have to be shown upon importation and unregistered devices could be detained by officials at the border. The devices captured under this provision are aligned with those for the import and sales that must be reported in the United States. A new schedule to the CDSA would be created, allowing additional devices to be controlled in the future to respond to changes in illicit drug production.
The proposed legislation would enable better information sharing about imports of pill presses and encapsulators with border officials and police forces during an investigation.
The proposed legislation will enable better information sharing about imports of pill presses and encapsulators with border officials and police forces in the course of an investigation.
Bill C-37 would also make amendments to expand the offences and punishments for pre-production activities of any controlled substance. Pre-production includes buying and assembling the chemical ingredients and industrial equipment that are intended to be used to make illicit drugs, but are not specifically listed in the CDSA schedules. These activities are not currently controlled under the CDSA unless the intent is to produce methamphetamine.
Members of the House may recall that concerns about the growing popularity of methamphetamine prompted private member's bill, Bill C-475, An Act to amend the Controlled Drugs and Substances Act (methamphetamine and ecstasy), in 2011. The passage of this bill made it illegal to possess, produce, sell, or import chemicals with the knowledge that they would be used to produce or traffic methamphetamine.
Given the growing opioid crisis and the evidence of illegal production of other drugs in Canada, including fentanyl, we must go further. The amendments proposed in Bill C-37 would extend the provisions that were added in 2011 so that penalties would apply to the illegal production, distribution, import, export, and transport of anything used to produce or traffic any controlled substance.
Given the growing opioid crisis and the evidence of illegal production of other drugs in Canada, including fentanyl, we must go further. The amendments proposed in Bill C-37 will extend the provisions that were added in 2011 so penalties will apply to the illegal production, distribution, import, export, and transport of anything used to produce or traffic any controlled substance.
The government recognizes the complex challenges faced by individuals who are involved in problematic substance use. We remain committed to working with our territorial and provincial partners to address the issues related to illegal drug use.
The government recognizes the complex challenges faced by individuals who are involved in problematic substance use. We remain committed to working with our territorial and provincial partners to address the issues related to illegal drug use.
Bill C-37 is one part of our government's response to Canada's growing opioid crisis. The legislative changes proposed in the bill will make the CDSA a more robust act and increase law enforcement's ability to take early action against suspected drug production operations, and better equip enforcement to respond to the evolution of the illicit drug market.
I encourage all members of this House to support this bill.